Pricing Log in Create free account

Biorestorative Therapies, Inc. (BRTX) vs Silexion Therapeutics Corp (SLXN)

Biorestorative Therapies, Inc. and Silexion Therapeutics Corp are both Biotechnology companies. Biorestorative Therapies, Inc. and Silexion Therapeutics Corp are of similar size ($2.2M and $2.1M). Silexion Therapeutics Corp has the higher net margin (0.00% vs −3,089.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Biorestorative Therapies, Inc. leads on 7 and Silexion Therapeutics Corp on 5.

Valuation

Metric BRTX SLXN Biotechnology median
P/E n/m n/m 10.60
P/S 3.67 n/m 9.40
P/B 0.43 2.19 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.15 0.04 0.66
EV/Sales (5.84) n/m 9.02
Earnings yield (1,445.95%) (40,328.57%) (32.88%)
Free cash flow yield (999.27%) (12,933.04%) (23.13%)

Profitability

Metric BRTX SLXN Biotechnology median
Gross margin 92.09% — 68.51%
Operating margin (3,974.66%) 0.00% 0.00%
Net margin (3,089.30%) 0.00% 0.00%
Free cash flow margin (3,302.04%) 0.00% 0.00%
Return on equity (241.50%) (17,021.95%) (51.96%)
Return on assets (147.75%) (277.96%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BRTX SLXN Biotechnology median
Revenue growth (TTM) (8.47%) — 6.76%
EPS growth (last fiscal year) (36.21%) 97.73% 29.88%
Revenue growth, 5-year CAGR 36.11% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BRTX SLXN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.35 0.94 4.97
Net debt to EBITDA 0.19 0.38 1.01

Dividend

Metric BRTX SLXN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BRTX SLXN Biotechnology median
Market cap 2.09m 2.19m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack